Clozapine, an update.

Keshavan, Matcheri S; Bishop, Danielle L; Coconcea, Cristinel; Bishop, Jeffrey R

Keshavan, Matcheri S; Bishop, Danielle L; Coconcea, Cristinel; Bishop, Jeffrey R.

Keshavan MS; Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA. Electronic address: keshavanms@gmail.com.
Bishop DL; Department of Pharmacy, M Health Fairview St. Joseph's Hospital, St Paul, MN, USA.
Coconcea C; Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Bishop JR; Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, MN, USA; Department of Psychiatry and Behavioral Sciences, University of Minnesota Medical School, Minneapolis, MN, USA.

Schizophr Res ; 248: 168-170, 2022 10.

Article in English | MEDLINE | ID: covidwho-2042121

Subject(s)

Antipsychotic Agents; Clozapine; Schizophrenia; Humans; Clozapine/therapeutic use; Antipsychotic Agents/therapeutic use; Schizophrenia/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Clozapine Limits: Humans Language: English Journal: Schizophr Res Journal subject: Psychiatry Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google